Related Experiment Videos

Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in

Jian-Sheng Gong1, Mariko Kobayashi, Hideki Hayashi

  • 1Department of Dementia Research, National Institute for Longevity Sciences, 36-3 Gengo, Morioka, Obu, Aichi 474-8522, Japan.

Insights

Apolipoprotein E (apoE) isoform 3 (apoE3) facilitates greater cholesterol release from astrocytes than apoE4. This suggests apoE3-expressing astrocytes may better supply cholesterol to neurons, impacting Alzheimer's disease research.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Previous research indicated exogenous apolipoprotein E (apoE) promotes cholesterol release in an isoform-dependent manner.
  • The precise molecular mechanism behind apoE's isoform-dependent cholesterol release remained unclear.

Purpose of the Study:

  • To investigate the mechanism of endogenous apoE isoform-dependent cholesterol release.
  • To compare cholesterol release mediated by apoE3 and apoE4 isoforms in cultured astrocytes.

Main Methods:

  • Utilized cultured astrocytes from human apoE3 and apoE4 knock-in mice.
  • Analyzed cholesterol and phospholipid release into culture media.
  • Characterized high-density lipoprotein (HDL)-like particles associated with apoE and apoJ.

Main Results:

  • ApoE3-expressing astrocytes released approximately 2.5-fold more cholesterol than apoE4-expressing astrocytes.
  • Similar amounts of apoE3 and apoE4 were released in association with HDL-like particles of comparable sizes.
  • The molar ratio of cholesterol to apoE was significantly higher in apoE3-derived HDL-like particles compared to apoE4-derived ones.

Conclusions:

  • ApoE3 generates larger cholesterol-carrying HDL-like particles with fewer apoE molecules than apoE4.
  • ApoE3-expressing astrocytes demonstrate a superior capacity for cholesterol supply to neurons compared to apoE4-expressing astrocytes.
  • Findings offer new insights into apoE-related cholesterol metabolism alterations in Alzheimer's disease.

Related Concept Videos